Editorial Commentary
Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?
Abstract
Lyon et al. recently examined survival outcomes among patients with metastatic renal cell carcinoma (mRCC) treated with or without complete surgical metastasectomy (SM) during an era when targeted therapy and checkpoint inhibitors were available (1).